top of page
Latest News
Keep up with the latest at mDETECT
mDETECT featured in >75 newspapers across
Canada and interviewed by Global News
mDETECT founder wins 1st place at
pitch competitions
Dr. Wiginton wins first place at the Lab2Market Deep Tech Expo.
Dr. Wiginton receives first place check at the Capital Angel Network's
#MASHUP Event
Read the mDETECT Impact Story featured
by Mitacs
mDETECT secures $900k CIHR grant and
launches breast cancer clinical trial
Join Dr. Wiginton and Dr. Banting discuss
how mDETECT will help cancer patients
In this episode, we interview one of the co-founders of mDetect Inc. - Dr. Irsa Wiginton. Dr. Wiginton holds a PhD in Biochemistry and Cell Biology from Queen's University. mDetect is commercializing a novel 'liquid biopsy' technology to support the treatment of cancer.
Pitch Winners!
Both our founders have been successful in several pitch competitions! Check out some of their stories below.
Congrats to Dr. Mueller for winning second place at the Mitacs Invention to Innovation (i2I) Skills Training Final Pitch Competition.
Congrats to Dr. Wiginton for winning first place at the Kingston Syracuse Pathway Pitch Competition.
New mDETECT blood test helps with earlier
cancer detection and better treatment
June 16, 2021: Queen’s researcher Christopher Mueller has developed a breast cancer
detection test that provides real time response to chemotherapy and early detection of relapse.
bottom of page